| "Prioritising" Pharmaceutical Patents in India? |
| Donnerstag, 29. Juli 2010 um 01:09 Uhr | ||||||
|
Many pharma patent cases (including the Novartis Gleevec case and the Roche Valcyte case) raise the issue of "relevant" priority dates.Tahir Amin dealt with this issue at length in this wonderful Zum Artikel: SPICY IP
Powered by !JoomlaComment 4.0alpha3
!joomlacomment 4.0 Copyright (C) 2009 Compojoom.com . All rights reserved." |

